Company Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Group companies

Sector

Sector Diagnostic & Testing Substances

Market Closed - Nasdaq Stockholm Other stock markets 16:19:35 17/05/2024 BST			5-day change	1st Jan Change
0.1195 ^SEK	+10.65%		-25.78%	-49.79%

02-14	Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-14	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Bio Vitos Pharma AB, formerly Hemcheck Sweden AB, is a Sweden-based medical technology company. The Company produces and commercializes a service for near-patient detection of hemolysis in blood samples. The concept consists of disposable tests as well as readers that can quickly, directly upon sampling, identify hemolysed blood samples in vacuum tubes and blood gas syringes. The Company's, ruptured red blood cells, is a common reason globally why blood samples cannot be analyzed accurately and is also a biomarker for acute medical conditions. Its goal is to contribute to improved healthcare by offering user-friendly solutions for the detection of hemolysed blood samples in direct connection with blood sampling near the patient. By doing so, the Company can contribute to increased patient safety, more efficient processes and lower costs.

Number of employees: 1

SEK in Million	2021	Weight	2022	Weight	Delta
Medical Devices 100.0 %	1	100.0 %	1	100.0 %	+17.78%

SEK in Million	2021	Weight	2022	Weight	Delta
Sweden 100.0 %	1	100.0 %	1	100.0 %	+17.78%

Managers	Title	Age	Since
Joen Averstad CEO	Chief Executive Officer	40	31/12/11
Robert Thorén DFI	Director of Finance/CFO	47	31/12/15

Members of the board	Title	Age	Since
Per Hjalmar Olof Didrikson FOU	Founder	50	31/12/09
Anders Mathias Karlsson FOU	Founder	52	31/12/09
Karin Cecilia Dahllöf BRD	Director/Board Member	65	31/12/17
Anna Klevby Dalgaard CHM	Chairman	45	31/12/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	5,030,000	0	0	7.118 %
Stock B	1	294,020,946	21,287,609 ( 7.240 %)	0

Hemcheck Sweden AB

Nanna Svartz väg 4

171 65, Solna

+46 5 42 02 22 11

http://www.hemcheck.se

Name	Category and Sector
Hemcheck Holding AB Hemcheck Holding AB Financial ConglomeratesFinance Hemcheck Holding AB engages in the acquisition of all shares in Hemcheck Management AB. The company was founded on April 14, 2023 and is headquartered in Solna, Sweden.	Financial Conglomerates

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
BIO VITOS PHARMA AB	-49.79%	3.28M
BIOMÉRIEUX	-4.67%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.19%	8.07B
DIASORIN S.P.A.	+9.45%	5.91B
LANTHEUS HOLDINGS, INC.	+28.50%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-8.09%	4.21B
10X GENOMICS, INC.	-55.31%	2.99B
ANDON HEALTH CO., LTD.	+13.49%	2.73B
VITROLIFE AB	-1.34%	2.43B
MYRIAD GENETICS, INC.	+32.24%	2.29B

Diagnostic & Testing Substances